AMPHENOL CORP /DE/ (APH) earnings date, results and what the price requires
NYSE · SEC CIK 0000820313 · SEC filings checked Oct 16, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 29, 2026 | $8.76B | $1.77B | $1.37 | Filing |
| Mar 31, 2026 | Apr 29, 2026 | $7.62B | $933.0M | $0.72 | Filing |
| Dec 31, 2025 | Jan 28, 2026 | $6.44B | $1.20B | $0.93 | Filing |
| Sep 30, 2025 | Oct 22, 2025 | $6.19B | $1.25B | $0.97 | Filing |
| Jun 30, 2025 | Jul 23, 2025 | $5.65B | $1.09B | $0.86 | Filing |
| Mar 31, 2025 | Apr 23, 2025 | $4.81B | $737.8M | $0.58 | Filing |
| Dec 31, 2024 | Jan 22, 2025 | $4.32B | $746.1M | $0.59 | Filing |
| Sep 30, 2024 | Oct 23, 2024 | $4.04B | $604.4M | $0.48 | Filing |
What would AMPHENOL CORP /DE/ have to report for its valuation to change?
At $81.49, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 11.8% a year, to $6.97. On that path the next quarter needs diluted EPS near $1.08, against $0.97 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 11.8% | 11.8% |
| EPS needed in final year | $6.97 | $6.97 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. APH goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.